Original paper

Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti–Vascular Endothelial Growth Factor Treatment

Volume: 123, Issue: 4, Pages: 850 - 857
Published: Apr 1, 2016
Abstract
To evaluate visual and anatomic outcomes after intravitreal aflibercept injection (IAI) versus laser in diabetic macular edema (DME) patients with and without prior anti-vascular endothelial growth factor (VEGF) treatment for DME.Post hoc analysis of eyes from 2 similarly designed, phase 3 trials, VISTA and VIVID.Patients (eyes) with DME with central involvement from VISTA (n = 461) and VIVID (n = 404).Eyes received IAI 2 mg every 4 weeks (2q4),...
Paper Details
Title
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti–Vascular Endothelial Growth Factor Treatment
Published Date
Apr 1, 2016
Volume
123
Issue
4
Pages
850 - 857
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.